Sales rise 13.19% to Rs 492.96 crore
Net profit of Caplin Point Laboratories rose 18.57% to Rs 138.96 crore in the quarter ended December 2024 as against Rs 117.20 crore during the previous quarter ended December 2023. Sales rose 13.19% to Rs 492.96 crore in the quarter ended December 2024 as against Rs 435.50 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var.Sales492.96435.50 13 OPM %32.9232.67 -PBDT193.46159.31 21 PBT177.26145.41 22 NP138.96117.20 19Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
